EN
抗体药类似物
Research Grade Maftivimab
All
TD-VK623056_1.jpg
  • CatalogTD-VK623056
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsREGN-3470-3471-3479,REGN-3470/REGN-3471/REGN-3479,INMAZEB™(odesivimab-ebgn,maftivimab,andatoltivimab),CAS:2135632-36-7
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Maftivimab


Catalog No. TD-VK623056
Species reactivity Zaire ebolavirus (ZEBOV)
Applications Research Grade Biosimilar
Host species Human
Isotype IgG1, kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target Envelope glycoprotein, GP1,2, GP, Shed GP, GP1,2-delta, GP1, GP2, GP
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession Q05320
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names REGN-3470-3471-3479,REGN-3470/REGN-3471/REGN-3479,INMAZEB™(odesivimab-ebgn,maftivimab,andatoltivimab),CAS:2135632-36-7
Background Maftivimab (REGN3470-3471-3479), the inhibitor of Filovirus, is an Food and agent Administration (FDA)-approved agent. Maftivimab, also named as Atoltivimab, Odesivimab (Inmazeb), can be used for research of Zaire ebolavirus infection.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-VK623056_1.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Maftivimab.